Fresh Equities

Loading presentation...

Announcements
announcement
  • FDA Orphan Drug Designation - Idiopathic Pulmonary Fibrosis

    Progress Report · Market sensitive

  • Quarterly Activities Report - March 2020 Qtr

    Commitments test entity quarterly reports · Market sensitive

  • App 4C - Quarterly Cash Flow Report - March 2020 Qtr

    Commitments test entity quarterly reports · Market sensitive

  • Shares to be Released from Voluntary Escrow

    Issued Capital

  • FDA Awards Orphan Drug Designation for Pancreatic Cancer

    Progress Report · Market sensitive

  • Professor Paul Timpson Joins Amplia's SAB

    Company Administration

  • Initial Director's Interest Notice - John Lambert

    Shareholder Details

  • Final Director's Interest Notice - Behrenbruch

    Shareholder Details

  • Final Director's Interest Notice - Wilkinson

    Shareholder Details

  • Final Director's Interest Notice - Cooke

    Shareholder Details

Market Data